Showing results (1831-1840 of 1,960) with videos related to
Sort By:
Pageof 196
Cancer|March 14, 2018
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptorGlenwood D Goss, Everett E Vokes, Michael S Gordon, et al.Haematologica|June 15, 2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphomaOmran Saifi, William G Breen, Scott C Lester, et al.Bioorganic & Medicinal Chemistry Letters|May 15, 2023
Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitorsAndrew J Wilkinson, Nicola Ooi, Jonathan Finlayson, et al.Regulatory Toxicology and Pharmacology : RTP|August 14, 2021
Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredientsM P Dent, E Vaillancourt, R S Thomas, et al.Blood|August 3, 2012
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomasGeorge Vasmatzis, Sarah H Johnson, Ryan A Knudson, et al.Cancer Research Communications|June 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin LymphomaEdgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, et al.Blood Cancer Journal|July 16, 2021
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphomaPatrizia Mondello, Angelo Fama, Melissa C Larson, et al.Cytokine|September 7, 2013
Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohortsHervé Ghesquières, Matthew J Maurer, Olivier Casasnovas, et al.Breast Cancer Research : BCR|June 10, 2024
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancerRoberto A Leon-Ferre, Kaitlyn R Whitaker, Vera J Suman, et al.Blood|December 17, 2025
PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphomaSanjal H Desai, Alison J Moskowitz, Reid W Merryman, et al.Pageof 196